These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26345275)

  • 1. Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
    Noli C; Cena T
    Vet Dermatol; 2015 Dec; 26(6):481-3, e112-3. PubMed ID: 26345275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a questionnaire to evaluate the Quality of Life of cats with skin disease and their owners, and its use in 185 cats with skin disease.
    Noli C; Borio S; Varina A; Schievano C
    Vet Dermatol; 2016 Aug; 27(4):247-e58. PubMed ID: 27292136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver reliability of Feline Dermatitis Extent and Severity Index (FEDESI) and Scoring Feline Allergic Dermatitis (SCORFAD) and the relationship between lesion scores and pruritus.
    Brame BE; Canning P; Morris DO; Drobatz KJ; Rook K; Cain CL
    Vet Dermatol; 2021 Oct; 32(5):492-e135. PubMed ID: 34338388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the correlation between Scoring Feline Allergic Dermatitis and Feline Extent and Severity Index and skin hydration in atopic cats.
    Szczepanik MP; Wilkołek PM; Adamek ŁR; Zając M; Gołyński M; Sitkowski W; Taszkun I
    Vet Dermatol; 2018 Feb; 29(1):34-e16. PubMed ID: 28901591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis.
    Szczepanik MP; Wilkołek PM; Adamek ŁR; Kalisz G; Gołyński M; Sitkowski W; Taszkun I
    Can J Vet Res; 2018 Oct; 82(4):306-311. PubMed ID: 30363310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis.
    Steffan J; Olivry T; Forster SL; Seewald W
    Vet Dermatol; 2012 Oct; 23(5):410-e77. PubMed ID: 22823903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial.
    Koch SN; Torres SMF; Diaz S; Gilbert S; Rendahl A
    Vet Dermatol; 2018 Apr; 29(2):107-e43. PubMed ID: 29068099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C; Noli C; Colombo S; Borio S
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study.
    Maina E; Fontaine J
    J Feline Med Surg; 2019 Oct; 21(10):967-972. PubMed ID: 30427273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective open pilot study on the use of ciclosporin for feline allergic skin disease.
    Noli C; Scarampella F
    J Small Anim Pract; 2006 Aug; 47(8):434-8. PubMed ID: 16911110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis.
    Noli C; Matricoti I; Schievano C
    Vet Dermatol; 2019 Apr; 30(2):110-e30. PubMed ID: 30656750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study.
    Schmidt V; Buckley LM; McEwan NA; Rème CA; Nuttall TJ
    Vet Dermatol; 2012 Feb; 23(1):11-6, e3-4. PubMed ID: 21718369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis.
    Roberts ES; Speranza C; Friberg C; Griffin C; Steffan J; Roycroft L; King S
    J Feline Med Surg; 2016 Nov; 18(11):889-897. PubMed ID: 26965676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral dexamethasone sodium phosphate solution significantly reduces pruritus and clinical lesions in feline hypersensitivity dermatitis: an open-label study.
    McClintock D; Austel M; Gogal RM; Banovic F
    Vet Dermatol; 2021 Oct; 32(5):497-e137. PubMed ID: 34351657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis.
    King S; Favrot C; Messinger L; Nuttall T; Steffan J; Forster S; Seewald W
    Vet Dermatol; 2012 Oct; 23(5):440-e84. PubMed ID: 22882582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
    Wisselink MA; Willemse T
    Vet J; 2009 Apr; 180(1):55-9. PubMed ID: 18294881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
    Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
    Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of methylprednisolone and triamcinolone for the induction and maintenance treatment of pruritus in allergic cats: a double-blinded, randomized, prospective study.
    Ganz EC; Griffin CE; Keys DA; Flatgard TA
    Vet Dermatol; 2012 Oct; 23(5):387-e72. PubMed ID: 22681547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an owner-assessed Visual Analog Scale for feline pruritus severity scoring (VAScat).
    Colombo S; Sartori R; Schievano C; Borio S
    Vet Dermatol; 2022 Oct; 33(5):407-413. PubMed ID: 35920060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study.
    Noli C; Della Valle MF; Miolo A; Medori C; Schievano C;
    Vet Dermatol; 2019 Oct; 30(5):387-e117. PubMed ID: 31237065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.